Management of uveitis: A rheumatologic perspective

Arthritis and Rheumatism

Volumn 46, Issue 2, 2002, Pages 309-318

  Smith, Justine R ^a   Rosenbaum, James T ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ETANERCEPT; HLA B27 ANTIGEN; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; LYMPHOCYTE ANTIGEN; TUMOR NECROSIS FACTOR;

BEHCET DISEASE; CELL INFILTRATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTERSTITIAL NEPHRITIS; IRIDOCYCLITIS; PRIORITY JOURNAL; RETINA VASCULITIS; REVIEW; RHEUMATOLOGY; UVEITIS;

HUMANS; IMMUNOSUPPRESSION; UVEITIS;

EID: 0036172079     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.503     Document Type: Review

References (58)

1. The natural course of uveitis
2. Uveitis: An internist's view
3. Referral patterns of uveitis in a tertiary eye care center
4. International Uveitis Study Group Recommendations for the evaluation of intraocular inflammatory disease
5. Polymerase chain reaction-based assays of vitreous samples for the diagnosis of viral retinitis: Use in diagnostic dilemmas
6. Drug-induced uveitis: Incidence, prevention and treatment
7. An algorithm for the systemic evaluation of patients with uveitis: Guidelines for the consultant
8. The utility of routine screening of patients with uveitis for systemic lupus erythematosus or tuberculosis: A Bayesian analysis
9. Prevalence of Lyme disease among patients with uveitis
10. Characterisation of uveitis in patients with psoriatic arthritis
11. Uveitis associated with inflammatory bowel disease compared with uveitis associated with spondyloarthropathy
12. Immune recovery uveitis
13. Tubulointerstitial nephritis and uveitis syndrome: Recognizing the importance of an uncommon disease
14. Characterization of uveitis associated with spondyloarthritis
15. Transient vitreous inflammatory reactions associated with combination antiretroviral therapy in patients with AIDS and cytomegalovirus retinitis
16. Immune recovery vitritis associated with inactive cytomegalovirus retinitis
17. Long-term posterior and anterior segment complications of immune recovery uveitis associated with cytomegalovirus retinitis
18. Acute eosinophilic interstitial nephritis and renal failure with bone marrow-lymph node granulomas and anterior uveitis
19. Clinical and immune aspects of idiopathic acute tubulointerstitial nephritis and uveitis syndrome
20. Course and outcome of tubulointerstitial nephritis and uveitis syndrome
21. Immunomodulatory therapy for chronic tubulointerstitial nephritis-associated uveitis
22. Retinal vasculitis - A primer
23. The management of thrombosis in the antiphospholipid-antibody syndrome
24. Cataract surgery in children with chronic uveitis
25. The diagnosis and management of uveitis
26. Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: Recommendations of an expert panel
27. Differential efficacy of tumor necrosis factor inhibition in the treatment of inflammatory eye disease and associated rheumatic disease
28. Etanercept therapy in children with treatment-resistant uveitis
29. Interferon α for ocular Behcet's disease
30. Treatment of ocular symptoms of Behcet's disease with interferon α2a: A pilot study
31. Efficacy of interferon alfa-2a in severe and refractory uveitis associated with Behcet's disease
32. Campath-1H therapy in refractory ocular inflammatory disease
33. Treatment of noninfectious intermediate and posterior uveitis with the humanized anti-Tac mAb: Phase I/II clinical trial
34. Treatment of endogenous uveitis with anti-CD4 monoclonal antibody: First report
35. The treatment of refractory uveitis with intravenous immunoglobulin
36. Intravenous immunoglobulin (IVIg) for treatment of birdshot retinochoroidopathy
37. Fluocinolone acetonide sustained drug delivery device to treat severe uveitis
38. Prevention of acute anterior uveitis associated with spondyloarthropathy induced by salazosulfapyridine
39. Sulfasalazine in recurrent anterior uveitis: A new therapeutical strategy
40. Treatment of uveitis by oral administration of retinal antigens: Results of a phase I/Il randomized masked trial
41. Effects of a loading dose regimen of three infusions of chimeric monoclonal antibody to tumour necrosis factor alpha (infliximab) in spondyloarthropathy: An open pilot study
42. Etanercept in children with polyarticular juvenile rheumatoid arthritis: Pediatric rheumatology collaborative study group
43. A short-term study of chimeric monoclonal antibody cA2 of tumor necrosis factor α for Crohn's disease
44. Cytokine mRNA levels in rat tissues after systemic endotoxin treatment
45. Kinetics of intraocular tumor necrosis factor and interleukin-6 in endotoxin-induced uveitis
46. Mice deficient in TNFR p55 and p75, IL-4 or iNOS are susceptible to endotoxin-induced uveitis
47. The paradoxical effect of tumor necrosis factor alpha (TNF-α) in endotoxin-induced uveitis
48. Pharmacotherapy for Behcet's syndrome
49. Interferon alfa-2b, colchicine, and benzathine penicillin versus colchicine and penicillin in Behcet's disease: A randomised trial
50. Behcet's disease: Treatment with alpha-interferon
51. Experimental autoimmune uveitis in the athymic nude rat
52. Experimental melanin-induced uveitis in the Fischer 344 rat is inhibited by anti-CD4 monoclonal antibody, but not by mannose-6-phosphate
53. Adhesion molecules in iris biopsy specimens from patients with uveitis
54. Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor
55. Intravitreal sustained-release dexamethasone device in the treatment of experimental uveitis
56. Intravitreal sustained-release cyclosporine in the treatment of experimental uveitis
57. Effect of an intravitreal cyclosporine implant on experimental uveitis in horses
58. Ciprofloxacin treatment does not influence course or relapse rate of reactive arthritis and anterior uveitis